Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Reiser

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|July 15, 2021
ALKBH1 reduces DNA N6-methyladenine to allow for vascular calcification in chronic kidney diseaseKe Zhu, Jochen Reiser
Pflugers Archiv : European Journal of Physiology|July 10, 2017
suPAR and chronic kidney disease-a podocyte storyMartin Zeier, Jochen Reiser
Journal of the American Society of Nephrology : JASN|September 2, 2004
Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndromeJochen Reiser, Peter Mundel
Annual Review of Medicine|November 30, 2012
Podocyte biology and pathogenesis of kidney diseaseJochen Reiser, Sanja Sever
Kidney International|November 20, 2009
Proteinuria: an enzymatic disease of the podocyte?Peter Mundel, Jochen Reiser
American Journal of Physiology. Renal Physiology|October 21, 2016
Stop that podocyte!Vineet Gupta, Jochen Reiser
Journal of the American Society of Nephrology : JASN|November 1, 2024
Treatment of Podocytopathies: Risky Business and Our Personal JourneySanja Sever, Jochen Reiser
Journal of the American Society of Nephrology : JASN|May 3, 2014
Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shakenJochen Reiser, Harold Chapman
Current Hypertension Reports|January 8, 2008
Dual effects of RAS blockade on blood pressure and podocyte functionJochen Reiser, Peter Mundel
Nature Metabolism|April 6, 2023
XOR risk variants drive diabetic kidney diseaseKe Zhu, Jochen Reiser
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|July 15, 2021
ALKBH1 reduces DNA N6-methyladenine to allow for vascular calcification in chronic kidney diseaseKe Zhu, Jochen Reiser
Pflugers Archiv : European Journal of Physiology|July 10, 2017
suPAR and chronic kidney disease-a podocyte storyMartin Zeier, Jochen Reiser
Journal of the American Society of Nephrology : JASN|September 2, 2004
Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndromeJochen Reiser, Peter Mundel
Annual Review of Medicine|November 30, 2012
Podocyte biology and pathogenesis of kidney diseaseJochen Reiser, Sanja Sever
Kidney International|November 20, 2009
Proteinuria: an enzymatic disease of the podocyte?Peter Mundel, Jochen Reiser
American Journal of Physiology. Renal Physiology|October 21, 2016
Stop that podocyte!Vineet Gupta, Jochen Reiser
Journal of the American Society of Nephrology : JASN|November 1, 2024
Treatment of Podocytopathies: Risky Business and Our Personal JourneySanja Sever, Jochen Reiser
Journal of the American Society of Nephrology : JASN|May 3, 2014
Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shakenJochen Reiser, Harold Chapman
Current Hypertension Reports|January 8, 2008
Dual effects of RAS blockade on blood pressure and podocyte functionJochen Reiser, Peter Mundel
Nature Metabolism|April 6, 2023
XOR risk variants drive diabetic kidney diseaseKe Zhu, Jochen Reiser
Pageof 25